Intratumoral HLA-DR(−)/CD33(+)/CD11b(+) Myeloid-Derived Suppressor Cells Predict Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer

Capecitabine-based neoadjuvant chemoradiation therapy (nCRT) is currently the mainstay of treatment for locally advanced rectal cancer (LARC), prior to surgical tumor removal. While response to this treatment is partial, it carries significant risk of side effects. As of today, there is no accepted...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasnis, Erez, Dahan, Aviva, Khoury, Wissam, Duek, Daniel, Fisher, Yael, Beny, Alex, Shaked, Yuval, Chowers, Yehuda, Half, Elizabeth E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435035/
https://www.ncbi.nlm.nih.gov/pubmed/32903466
http://dx.doi.org/10.3389/fonc.2020.01375

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7435035/
https://www.ncbi.nlm.nih.gov/pubmed/32903466
http://dx.doi.org/10.3389/fonc.2020.01375

Ejemplares similares